The Current Opinion journal series is comprised of up-to-date, peer-reviewed scientific journals, that provide scientists with an easy way to remain informed of all the latest developments within their fields of interest. They are available individually or as a set on a subscription basis.

For information about institutional subscriptions and free trials visit our library information pages or contact institutions@biomedcentral.com. For corporate and personal online subscriptions please email ts.custserv.emea@thomson.com.

There are 4 titles in the series, each covering a specific area of Pharmaceutical R&D

• Current Opinion in Drug Discovery & Development is published bimonthly and focuses on the chemical aspects of drug discovery and development.
   
• Current Opinion in Investigational Drugs is published monthly and delivers systematic and comprehensive coverage of the following therapeutic areas:
  • Anti-infectives
  • Anti-inflammatory, immune-meditated and gastrointestinal
  • Cardiovascular, renal and metabolic
  • Central and peripheral nervous system
  • Oncological
  
   
• Current Opinion in Molecular Therapeutics is published bimonthly and covers the broad field of molecular medicine, including viral and non-viral gene therapy, oligonucleotides, peptide therapeutics, antibody approaches, molecular vaccines, and the technologies underlying genomics and proteomics.
   
• IDrugs: The Investigational Drugs Journal brings you up to the minute reports on breakthroughs in research via unparalleled coverage of scientific meetings.